Thiabendazole indications and usage: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) |
Gerald Chi (talk | contribs) |
||
| Line 15: | Line 15: | ||
* [[Trichinosis]]: Relief of symptoms and [[fever]] and a reduction of [[eosinophilia]] have followed the use of MINTEZOL during the invasion stage of the disease. | * [[Trichinosis]]: Relief of symptoms and [[fever]] and a reduction of [[eosinophilia]] have followed the use of MINTEZOL during the invasion stage of the disease. | ||
Thiabendazole is usually inappropriate as first line therapy for [[enterobiasis]] (pinworm). However, when enterobiasis occurs with any of the conditions listed above, additional therapy is not required for most patients. | Thiabendazole is usually inappropriate as first line therapy for [[enterobiasis]] ([[pinworm]]). However, when enterobiasis occurs with any of the conditions listed above, additional therapy is not required for most patients. | ||
MINTEZOL should be used only in the following infestations when more specific therapy is not available or cannot be used or when further therapy with a second agent is desirable: | MINTEZOL should be used only in the following infestations when more specific therapy is not available or cannot be used or when further therapy with a second agent is desirable: | ||
Latest revision as of 04:27, 12 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Indications and Usage
MINTEZOL is indicated for the treatment of:
- Cutaneous larva migrans (creeping eruption)
- Trichinosis: Relief of symptoms and fever and a reduction of eosinophilia have followed the use of MINTEZOL during the invasion stage of the disease.
Thiabendazole is usually inappropriate as first line therapy for enterobiasis (pinworm). However, when enterobiasis occurs with any of the conditions listed above, additional therapy is not required for most patients.
MINTEZOL should be used only in the following infestations when more specific therapy is not available or cannot be used or when further therapy with a second agent is desirable:
- Ascariasis (large roundworm)[1]
References
- ↑ "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/16096slr033,16097slr026_mintezol_lbl.pdf" (PDF). External link in
|title=(help)
Adapted from the FDA Package Insert.